1.
Armstrong AW, Bissonnette R, Brown PM, Tallman AM, Papp KA. Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.22];6(6):s52. Available from: https://jofskin.org/index.php/skin/article/view/1807